Leukapheresis Global Market Report 2025

Description

Leukapheresis is a medical procedure that involves the separation and removal of white blood cells (leukocytes) from a patient's blood. The remaining blood components, such as red blood cells and plasma, are then returned to the body. This technique is used to treat conditions with elevated white blood cell counts or to collect specific immune cells for research or therapeutic purposes.

The main types of leukapheresis include granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis is a procedure that selectively isolates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products related to this procedure include leukapheresis devices, centrifugal devices, membrane separators, and disposables. Applications of leukapheresis extend to research areas such as cancer research, immunology, hematologic disorders, autoimmune diseases, and others. These procedures are utilized by blood component providers, blood centers, academic and research institutions, pharmaceutical and biotechnology companies, and hospitals and transfusion centers.

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides leukapheresis market statistics, including the leukapheresis industry global market size, regional shares, competitors with the leukapheresis market share, detailed leukapheresis market segments, market trends, and opportunities, and any further data you may need to thrive in the leukapheresis industry. This leukapheresis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The leukapheresis market size has grown strongly in recent years. It will grow from $66.80 billion in 2024 to $72.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. Growth during the historic period can be attributed to the increasing prevalence of leukemia and autoimmune diseases, rising demand for personalized medicine, advancements in stem cell research, improvements in apheresis technologies, expanding clinical trial activities, and greater awareness of immunotherapy applications.

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $97.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. Growth in the forecast period is expected to be driven by rising demand for personalized cell therapies, an increase in clinical trials in immuno-oncology, growing adoption in regenerative medicine, expansion of biopharmaceutical manufacturing, improved reimbursement policies, and greater awareness of cell-based research and treatment options. Key trends in the forecast period include advancements in cell separation technologies, integration of AI for optimizing procedures, development of portable leukapheresis devices, progress in cell and gene therapy, enhanced donor screening methods, and the adoption of cloud-based data tracking systems.

The growing incidence of autoimmune diseases is anticipated to drive the expansion of the leukapheresis market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy tissues. Factors such as reduced early-life microbial exposure and modern environmental influences are disrupting immune balance, leading to an increase in autoimmune disorders. Leukapheresis aids in treating these diseases by selectively removing harmful white blood cells that contribute to the immune system's attack on the body. For example, according to a report by Versorgungsatlas.de, a Germany-based organization, in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a prevalence rate of 8.61%. Thus, the rise in autoimmune diseases is fueling the growth of the leukapheresis market.

Leading companies in the leukapheresis market are focusing on innovations such as the development of GMP-grade leukopaks to improve the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under stringent good manufacturing practice (GMP) standards, ensuring high cell viability and functionality for therapeutic use. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, introduced LeukoCer, a GMP-grade leukopak designed to streamline workflows and speed up cell therapy development. LeukoCer provides high-quality starting materials in fresh whole or half packs, produced according to strict GMP standards, enabling researchers to advance their work and accelerate the introduction of new cell therapies to the market.

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, formed a partnership with Cyto-care.eu GmbH to enhance the cryopreservation process for cell therapy in Europe. The collaboration focuses on improving the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are vital components in the production of advanced cell therapy products (ATMPs). Cyto-care.eu GmbH, based in Austria, specializes in providing cell products for biomedical research, drug discovery, and cell and gene therapy.

Major players in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, and Adacyte Therapeutics.

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in leukapheresis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukapheresis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukapheresis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leukapheresis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Granulocyte Apheresis; Lymphocyte Apheresis; Monocyte Apheresis
2) By Product: Leukapheresis Devices; Centrifugal Devices; Membrane Separators; Leukapheresis Disposables
3) By Application: Research Application; Cancer Research; Immunology Research; Therapeutics Application; Hematologic Disorders; Autoimmune Diseases; Other Applications
4) By End User: Blood Component Providers And Blood Centers; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Transfusion Centers
Subsegments:
1) By Granulocyte Apheresis: Neutrophil Apheresis; Eosinophil Apheresis; Basophil Apheresis
2) By Lymphocyte Apheresis: T-Cell Apheresis; B-Cell Apheresis; Natural Killer (NK) Cell Apheresis
3) By Monocyte Apheresis: Classical Monocytes; Non-Classical Monocytes; Intermediate Monocytes
Companies Mentioned: Fresenius Kabi; Grifols S.A.; Terumo BCT Inc.; Nikkiso Co.; STEMCELL Technologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35468

1. Executive Summary

2. Leukapheresis Market Characteristics

3. Leukapheresis Market Trends And Strategies

4. Leukapheresis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukapheresis Growth Analysis And Strategic Analysis Framework

5.1. Global Leukapheresis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Leukapheresis Market Growth Rate Analysis
5.4. Global Leukapheresis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Leukapheresis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Leukapheresis Total Addressable Market (TAM)

6. Leukapheresis Market Segmentation

6.1. Global Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Granulocyte Apheresis
Lymphocyte Apheresis
Monocyte Apheresis
6.2. Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukapheresis Devices
Centrifugal Devices
Membrane Separators
Leukapheresis Disposables
6.3. Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Application
Cancer Research
Immunology Research
Therapeutics Application
Hematologic Disorders
Autoimmune Diseases
Other Applications
6.4. Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Component Providers And Blood Centers
Academic And Research Institutes
Pharmaceutical And Biotechnology Companies
Hospitals And Transfusion Centers
6.5. Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neutrophil Apheresis
Eosinophil Apheresis
Basophil Apheresis
6.6. Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
T-Cell Apheresis
B-Cell Apheresis
Natural Killer (NK) Cell Apheresis
6.7. Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Classical Monocytes
Non-Classical Monocytes
Intermediate Monocytes

7. Leukapheresis Market Regional And Country Analysis

7.1. Global Leukapheresis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Leukapheresis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Market

8.1. Asia-Pacific Leukapheresis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Market

9.1. China Leukapheresis Market Overview
9.2. China Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Market

10.1. India Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Market

11.1. Japan Leukapheresis Market Overview
11.2. Japan Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Market

12.1. Australia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Market

13.1. Indonesia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Market

14.1. South Korea Leukapheresis Market Overview
14.2. South Korea Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Market

15.1. Western Europe Leukapheresis Market Overview
15.2. Western Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Market

16.1. UK Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Market

17.1. Germany Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Market

18.1. France Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Market

19.1. Italy Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Market

20.1. Spain Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Market

21.1. Eastern Europe Leukapheresis Market Overview
21.2. Eastern Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Market

22.1. Russia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Market

23.1. North America Leukapheresis Market Overview
23.2. North America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Market

24.1. USA Leukapheresis Market Overview
24.2. USA Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Market

25.1. Canada Leukapheresis Market Overview
25.2. Canada Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Market

26.1. South America Leukapheresis Market Overview
26.2. South America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Market

27.1. Brazil Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Market

28.1. Middle East Leukapheresis Market Overview
28.2. Middle East Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Market

29.1. Africa Leukapheresis Market Overview
29.2. Africa Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Market Competitive Landscape And Company Profiles

30.1. Leukapheresis Market Competitive Landscape
30.2. Leukapheresis Market Company Profiles
- 30.2.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Market Other Major And Innovative Companies

31.1. Haemonetics Corporation
31.2. Macopharma
31.3. Discovery Life Sciences
31.4. BioIVT LLC
31.5. StemExpress LLC
31.6. MEDICA S.p.A
31.7. AllCells LLC
31.8. Caltag Medsystems Ltd.
31.9. Miltenyi Biotec
31.10. Immune Therapy Holdings AB
31.11. Cellsep Laboratories
31.12. Accegen Biotec
31.13. Key Biologics LLC
31.14. HemaCare Corporation
31.15. Puriblood Medical

32. Global Leukapheresis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Market

34. Recent Developments In The Leukapheresis Market

35. Leukapheresis Market High Potential Countries, Segments and Strategies

35.1 Leukapheresis Market In 2029 - Countries Offering Most New Opportunities
35.2 Leukapheresis Market In 2029 - Segments Offering Most New Opportunities
35.3 Leukapheresis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer